<DOC>
	<DOCNO>NCT01537042</DOCNO>
	<brief_summary>This sleep laboratory study evaluate efficacy safety Rotigotine subject Restless Legs Syndrome End-Stage Renal Disease require hemodialysis . The objective demonstrate superiority Rotigotine Placebo well investigate effect Rotigotine quality life sleep .</brief_summary>
	<brief_title>A Sleep Laboratory Study Investigate Safety Efficacy Rotigotine Skin Patch Subjects With Restless Legs Syndrome End-Stage Renal Disease Requiring Hemodialysis</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Kidney Failure , Chronic</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<mesh_term>Psychomotor Agitation</mesh_term>
	<mesh_term>Restless Legs Syndrome</mesh_term>
	<mesh_term>N 0437</mesh_term>
	<criteria>EndStage Renal Disease ( ESRD ) require hemodialysis regular dialysis schedule Fulfillment predefined criterion hematology parameter Diagnosis Restless Legs ( RLS ) base 4 cardinal diagnostic clinical feature accord International Restless Legs Syndrome Study Group Initial response previous dopaminergic treatment RLS , previous dopaminergic treatment ( ie , de novo ) Score ≥ 15 point IRLS ( indicate moderate severe RLS ) Baseline Score ≥ 11 point RLSDI ( Diagnostic Index ) Baseline Score ≥ 4 point Clinical Global Impressions ( CGI ) Item 1 assessment ( indicate moderately ill ) Baseline Scores ≥ 15 Periodic Limb Movements ( PLMs ) per hour Periodic Limb Movement Index ( PLMI ) base Polysomnography ( PSG ) ( record second night ) assess investigator Baseline Clinically relevant Polyneuropathy Varicosis clearly differentiate RLS symptom opinion investigator Clinically relevant concomitant disease , Attention Deficit Hyperactivity Disorder , Painful Legs , Moving Toes Other central nervous system diseases Evidence impulse control disorder accord modify Minnesota Impulsive Disorders Interview ( mMIDI ) Lifetime history suicide attempt ( include active attempt , interrupt attempt , aborted attempt ) , suicidal ideation past 6 month indicate positive response ( 'yes ' ) either Question 4 Question 5 ColumbiaSuicidality Severity Rating Scale ( CSSRS ) Screening ( Visit 1 ) Baseline ( Visit 2 ) Prior history psychotic episode History symptomatic ( asymptomatic ) Orthostatic Hypotension Clinically relevant Cardiovascular Disease Clinically relevant Venous Arterial Peripheral Vascular Disease Malignant Neoplastic Disease require therapy within 12 month prior Screening ( Visit 1 ) Treatment follow drug class : neuroleptic , norepinephrine dopamine reuptake inhibitor ( bupropion ) , gabapentin , budipine , dopamine antagonist antiemetic ( except domperidone ) , opioids , monoamine oxidase ( MAO ) inhibitor , catechol‑O‑methyltransferase ( COMT ) inhibitor , psychostimulants ( eg , amphetamine ) Subject pregnant , nursing , woman childbearing potential surgically sterile , 2 year postmenopausal , consistently use 2 combined effective method contraception ( include least 1 barrier method ) , unless sexually abstinent Previous treatment dopamine agonist within period 14 day prior Baseline ( Visit 2 ) , Ldopa within 7 day prior Baseline ( Visit 2 ) Medical history indicate intolerability dopaminergic therapy ( pretreated ) experience Augmentation ( GarciaBorreguero Williams , 2010 ) previously treat dopaminergic agent Subject receive previous treatment Rotigotine Known hypersensitivity component study medication , history significant Skin Hypersensitivity adhesives , know Hypersensitivity transdermal medication , unresolved Contact Dermatitis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>October 2014</verification_date>
	<keyword>Rotigotine</keyword>
	<keyword>Neupro</keyword>
	<keyword>Restless Legs Syndrome</keyword>
	<keyword>RLS</keyword>
	<keyword>End-Stage Renal Disease</keyword>
</DOC>